Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04755764 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effect of Labetalol, Atenolol, and Nifedipine on Maternal Hemodynamics Measured by ICG in Early Pregnancy

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated May 13, 2025 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Primary completion date: Apr 2024 to Dec 2025
    • Study completion date: Dec 2024 to Dec 2025
    • Site contact updated
    v6
  2. Primary completion date: Dec 2022 to Apr 2024
    • Study completion date: Dec 2022 to Dec 2024
    v5
  3. Primary completion date: Jul 2022 to Dec 2022v4
  4. Primary completion date: Feb 2022 to Jul 2022v3
  5. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Feb 2021 to Mar 3, 2021
    v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of the research is to characterize the effect of labetalol, atenolol, and nifedipine on maternal hemodynamics early in pregnancy. Patients will be given medication based on their hemodynamics and asked to return for a repeat measurement.
Trial Details
NCT Number NCT04755764
Lead Sponsor Marshall University
Conditions
(from sponsor)		 Systolic Hypertension, Pregnancy Related, Diastolic Hypertension, Cardiac Output, Low, Cardiac Output, High
Related terms Cardiac Output, High, Cardiac Output, Low, Isolated Systolic Hypertension
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov